A detailed history of Farther Finance Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 29,737 shares of NVO stock, worth $3.13 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
29,737
Previous 26,600 11.79%
Holding current value
$3.13 Million
Previous $3.87 Billion 8.46%
% of portfolio
0.13%
Previous 0.19%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.07 - $145.42 $373,522 - $456,182
3,137 Added 11.79%
29,737 $3.54 Billion
Q2 2024

Jul 31, 2024

SELL
$122.71 - $146.91 $35,831 - $42,897
-292 Reduced 1.09%
26,600 $3.87 Billion
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $2.74 Million - $3.65 Million
26,861 Added 86648.39%
26,892 $3.43 Billion
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $2.58 Million - $3.1 Million
29,425 Added 654.33%
33,922 $3.51 Billion
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $406,138 - $891,145
4,466 Added 14406.45%
4,497 $409 Million
Q2 2023

May 13, 2024

SELL
$155.98 - $172.65 $5,303 - $5,870
-34 Reduced 52.31%
31 $5.02 Million
Q2 2023

Sep 12, 2023

SELL
$155.98 - $172.65 $5,303 - $5,870
-34 Reduced 52.31%
31 $5.02 Million
Q1 2023

May 13, 2024

SELL
$132.34 - $159.14 $4.48 Million - $5.39 Million
-33,857 Reduced 99.81%
65 $10.3 Million
Q1 2023

Sep 12, 2023

BUY
$132.34 - $159.14 $6,087 - $7,320
46 Added 242.11%
65 $10.3 Million
Q4 2022

Sep 11, 2023

BUY
$102.55 - $135.33 $1,948 - $2,571
19 New
19 $2.57 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.